other_material
confidence high
sentiment neutral
materiality 0.75
NanoVibronix raises $8M in private placement of Series H convertible preferred and warrants
ENvue Medical, Inc.
- Initial closing of $8M gross proceeds: 8,889 Series H preferred shares ($1,000 stated value, convertible at $1.01/sh) and warrants for 4,678,363 shares at $2.25/sh.
- Second closing of $2.22M (2,222 preferred shares) contingent on customary conditions.
- Net proceeds: $5M to redeem Series X preferred stock; remainder for working capital.
- Investor gets right to buy up to $44M additional preferred stock over 36 months at 85% of average VWAP.
- Company must seek stockholder approval for issuance exceeding 19.99% of outstanding common stock.
item 1.01item 2.03item 3.02item 3.03item 5.03